Metraipolis › archive › dc_a2aca49eb46b
Tumor-immune spatiotemporal co-evolution as a paradigm for overcoming therapy resistance in advanced prostate cancer — Europe PMC PMID:41890710
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41890710
- DOI
- 10.3389/fimmu.2026.1797299
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T19:56:22.196Z
- SHA-256 of the archived text
f9f3becb86d31fbd3a897a7b1be96f0139ac3a4108f49b1a8523dd39cab6e685- Stable URL of this page
https://metraipolis.com/documento/dc_a2aca49eb46b
How to cite
Tumor-immune spatiotemporal co-evolution as a paradigm for overcoming therapy resistance in advanced prostate cancer — Europe PMC PMID:41890710 — Europe PMC (en), https://europepmc.org/article/MED/41890710 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a2aca49eb46b (Metraipolis archive dc_a2aca49eb46b, sha256 f9f3becb86d31fbd3a897a7b1be96f0139ac3a4108f49b1a8523dd39cab6e685)
BibTeX
@misc{dca2aca49eb46b,
title = {Tumor-immune spatiotemporal co-evolution as a paradigm for overcoming therapy resistance in advanced prostate cancer — Europe PMC PMID:41890710},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41890710},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a2aca49eb46b; sha256 f9f3becb86d31fbd3a897a7b1be96f0139ac3a4108f49b1a8523dd39cab6e685},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41890710. Agents can read the archived copy with the MCP tool read_document.